Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,450 | 7 | 49.0% |
| Consulting Fee | $16,948 | 7 | 31.4% |
| Food and Beverage | $5,370 | 213 | 9.9% |
| Travel and Lodging | $4,870 | 10 | 9.0% |
| Education | $387.86 | 12 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $29,352 | 33 | $0 (2017) |
| Exelixis Inc. | $5,360 | 17 | $0 (2018) |
| Millennium Pharmaceuticals, Inc. | $5,046 | 5 | $0 (2017) |
| AbbVie, Inc. | $3,609 | 3 | $0 (2017) |
| Gilead Sciences Inc | $3,589 | 5 | $0 (2017) |
| Heron Therapeutics, Inc. | $2,723 | 2 | $0 (2017) |
| Lilly USA, LLC | $587.27 | 8 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $552.38 | 16 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $302.45 | 21 | $0 (2017) |
| Foundation Medicine, Inc. | $256.83 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18.46 | 1 | SERVIER PHARMACEUTICALS LLC ($18.46) |
| 2020 | $114.46 | 1 | E.R. Squibb & Sons, L.L.C. ($114.46) |
| 2018 | $5,244 | 6 | Exelixis Inc. ($5,233) |
| 2017 | $48,649 | 241 | AstraZeneca Pharmaceuticals LP ($29,352) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2023 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug), IDHIFA | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Oncology | ||||||
| 01/30/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $114.46 | General |
| Category: Oncology | ||||||
| 07/20/2018 | PFIZER INC. | RETACRIT (Biological) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: HEMATOLOGY | ||||||
| 04/20/2018 | Exelixis Inc. | Cabometyx (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Oncology | ||||||
| 04/20/2018 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $296.11 | General |
| Category: Oncology | ||||||
| 04/20/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $72.50 | General |
| Category: Oncology | ||||||
| 04/20/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $42.50 | General |
| Category: Oncology | ||||||
| 04/19/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Oncology | ||||||
| 11/06/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Hematology / Oncology | ||||||
| 09/26/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $2.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/22/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Hematology/Oncology | ||||||
| 09/21/2017 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Oncology | ||||||
| 09/21/2017 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Oncology | ||||||
| 09/20/2017 | Kyowa Kirin, Inc. | SANCUSO (Drug), FARESTON, IXEMPRA | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: ANTIEMETIC - 5HT3 INHIBITOR | ||||||
| 09/19/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), DARZALEX, YONDELIS | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Oncology | ||||||
| 09/14/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Hematology / Oncology | ||||||
| 09/14/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Endocrinology | ||||||
| 09/13/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $107.34 | General |
| Category: Oncology | ||||||
| 09/12/2017 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: Oncology | ||||||
| 09/11/2017 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Oncology | ||||||
| 09/11/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), VOTRIENT | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2017 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: Oncology | ||||||
| 09/07/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $51.00 | General |
| Category: ONCOLOGY | ||||||
| 09/07/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 400 | 477 | $94,166 | $37,317 |
| 2022 | 7 | 755 | 1,376 | $303,526 | $91,504 |
| 2021 | 7 | 575 | 1,007 | $247,086 | $84,362 |
| 2020 | 6 | 502 | 786 | $162,584 | $51,594 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 160 | 205 | $43,009 | $14,821 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 91 | 110 | $23,480 | $11,960 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 111 | 124 | $15,148 | $5,962 | 39.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 22 | 22 | $7,590 | $2,983 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $4,939 | $1,590 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 265 | 674 | $160,271 | $49,763 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 249 | 445 | $70,845 | $20,670 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 57 | 69 | $21,530 | $7,317 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 67 | 67 | $24,596 | $6,589 | 26.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 33 | 33 | $14,757 | $4,431 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 64 | 68 | $6,668 | $1,474 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 20 | 20 | $4,859 | $1,261 | 26.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 131 | 313 | $96,717 | $35,221 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 196 | 396 | $90,684 | $30,303 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 148 | 198 | $30,690 | $10,227 | 33.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 25 | 25 | $10,975 | $3,563 | 32.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 33 | 33 | $11,616 | $3,420 | 29.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 16 | 16 | $3,856 | $925.54 | 24.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 26 | 26 | $2,548 | $702.12 | 27.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 111 | 182 | $52,052 | $16,130 | 31.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 75 | 107 | $41,195 | $13,332 | 32.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 87 | 164 | $31,816 | $10,532 | 33.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 52 | 52 | $28,704 | $8,362 | 29.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 17 | $7,497 | $2,449 | 32.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 161 | 264 | $1,320 | $788.28 | 59.7% |
About Dr. Rodrigo Erlich, M.D
Dr. Rodrigo Erlich, M.D is a Internal Medicine healthcare provider based in Mason City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720039126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rodrigo Erlich, M.D has received a total of $54,026 in payments from pharmaceutical and medical device companies, with $18.46 received in 2023. These payments were reported across 249 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($26,450).
As a Medicare-enrolled provider, Erlich has provided services to 2,232 Medicare beneficiaries, totaling 3,646 services with total Medicare billing of $264,777. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology, Medical Oncology
- Location Mason City, IA
- Active Since 05/12/2006
- Last Updated 07/26/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720039126
Products in Payments
- IMFINZI (Drug) $29,236
- Cabometyx (Drug) $5,360
- ALUNBRIG (Drug) $4,892
- Venclexta (Drug) $3,609
- Zydelig (Drug) $3,575
- SUSTOL (Drug) $2,723
- CYRAMZA (Drug) $550.00
- OPDIVO (Biological) $508.98
- FOUNDATIONONE (Device) $256.83
- GILOTRIF (Drug) $170.11
- JEVTANA (Drug) $154.79
- Bromsite (Drug) $150.95
- NINLARO (Drug) $132.17
- ZALTRAP (Drug) $99.99
- ELIQUIS (Drug) $96.58
- Increlex-Somatuline (Drug) $93.81
- TASIGNA (Drug) $93.19
- AFINITOR (Drug) $92.89
- KYPHON Balloon Kyphoplasty (Device) $92.20
- TAGRISSO (Drug) $86.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mason City
Mark Johnson, Md, MD
Internal Medicine — Payments: $380,856
Dr. Richard Rattin, D.o, D.O
Internal Medicine — Payments: $14,533
Sepideh Darbandi, Do, DO
Internal Medicine — Payments: $8,241
Dr. Michael Spooner, M.d, M.D
Internal Medicine — Payments: $7,144
Noor Subah, Md, MD
Internal Medicine — Payments: $5,819
Dr. Natalia Ferrari Gabilondo, M.d, M.D
Internal Medicine — Payments: $3,912